Filing metadata

Accession number
0001209191-23-052586
Form type
Form 4
Filer
Anebulo Pharmaceuticals, Inc.
CIK
CIK 1815974
Filed
Oct 10, 2023
Reporting period
Oct 06, 2023
Description
Insider transaction

Explore SEC Filings Hub